|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update on AUA guideline on the management of benign prostatic hyperplasia显示文摘 | Mcvary K T Roehrborn C G Avins A L | 2011 | J Urol2011，185，5： | 1 |
| 2 | A ran domized trial comparing acupuncture, simulated acu puncture, and usual care for chronic low back pain显示文摘 | Cherkin D C Sherman K J Avins A L | 2009 | Arch Intern Med2009，169，9： | 1 |
| 3 | Up- date on AUA guideline on the management of benign prostatic hyperplasia显示文摘 | McVary K T Roehrborn C G Avins A L | 2011 | J Urol2011，185，： | 1 |
| 4 | Treatnt of high-grade spinal cord astrocytoma of childhood with '8-in-I ' chemotherapy and radiotherapy: a pilot study of CCG-945me 显示文摘 | Allen JC Aviner S Yates A J | 1998 | J Neurosurg1998，88，： | 1 |
| 5 | The deacetylase Sirtl is an essential regulator of Aire-mediated induction of central immunological tolerance显示文摘 | Chuprin A Avin A Goldfarb Y | 2015 | t Immunol2015，16，7： | 1 |
| 6 | Treatment strategies for chronic hepatitis C prior to andfollowing liver transplantation显示文摘Hepatitis C virus(HCV)-related liver disease is the leading indication for liver transplantation(LT) worldwide. However, HCV is an independent predictor of lower survival following LT, and recurrence of HCV postLT is virtually universal. The historic standard of care during the interferon era of HCV therapy was expectant management-initiation of antiviral therapy in the setting of documented disease progression following LT. With the advent of new direct acting antiviral(DAA) therapies for HCV, the paradigm of expectant treatment for recurrent HCV infection post-LT is shifting. The safety, tolerability, and efficacy of DAAs, even among the sickest patients with advanced liver disease, enables treatment of HCV in the pre-transplant setting among LT waitlist registrants. Finally, emerging data are supportive of preemptive therapy with DAAs in liver transplant recipients as the preferred approach. Expectant management of HCV following LT can rarely be justified in the modern era of HCV therapy. | Ryan B Perumpail Thomas A Hahambis Avin Aggarwal Zobair M Younossi Aijaz Ahmed | 2016 | World Journal of Hepatology2016，8，1： | 1 |
| 7 | Brief communication: Better ways to question patients about adverse medical events: A randomized, controlled trial显示文摘 | Bent S Padula A Avins AL | 2006 | Ann Intern Med2006，144，4： | 1 |
| 8 | The effects of cooperative learning and direct instruction in reading comprehension strategies on main idea identification显示文摘 | Stevens R J S] avin R E Famish A M | 1991 | Journal of Educational Psychology1991，，1： | 1 |
| 9 | A ran-domized trial comparing acupuncture, simulated acu-puncture, and usual care for chronic low back pain显示文摘 | Cherkin D C Sherman K J Avins A L | 2009 | Arch Intern Med2009，169，9： | 1 |
| 10 | Up- date on AUA guideline on the management of benign prostatic hyperplasia显示文摘 | MCVARY K T ROEHRBORN C G AVINS A L | 2011 | J Urol2011，185，： | 1 |
| 11 | Case-finding instruments for depression显示文摘 | Whooley M A Avins A L Browner W S | 1997 | J Gen Intern Med1997，12，7： | 1 |
| 12 | Molecular classificationand phylogenetic relationships of selected edibleBasidiomycetes species 显示文摘 | Avin F A Bhassu S Shin T Y | 2012 | Mol Biol Rep2012，39，7： | 1 |
| 13 | The deacetylase Sirtl is an essential regulator of Aire-mediated induction of central immunological tolerance 显示文摘 | Chuprin A Avin A Goldfarb Y | 2015 | Nat Immunol2015，16，7： | 1 |
| 14 | Spontaneous bleeding associated with Ginkgo biloba 显示文摘 | Goldberg SH Padula A Avins AL | 2005 | J Gen Intern Med2005，20，： | 1 |
| 15 | A randomized trial comparing acupuncture, simulated acupuncture, and u- sual care for chronic low back pain 显示文摘 | Cherkin D C Sherman K J Avins A L | 2009 | Arch Intern Med2009，169，9： | 1 |
| 16 | A ran- domized trial comparing acupuncture, simulated acu- puncture, and usualcare for chronic low back pain显示文摘 | Cherkin D C Sherman K J Avins A L | 2009 | Arch Intern Med2009，169，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员